Explore stories from Atlantic Canada.
PARIS - Sanofi on Friday announced it has reached a 'co-exclusive' licensing agreement with Novavax to sell a stand-alone COVID-19 vaccine and develop new flu-COVID-19 combination vaccines.
"We're excited by the prospect of combining Novavax's adjuvanted COVID-19 vaccine that has shown high efficacy and favorable tolerability, with our rich portfolio of differentiated flu vaccines ", Sanofi's head of vaccines R&D, Jean-Francois Toussaint, said in a statement.It has been our privilege to have the trust and support of our East Coast communities for the last 200 years. Our SaltWire team is always watching out for the place we call home.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
France's Sanofi in COVID-19 vaccine deal with NovavaxExplore stories from Atlantic Canada.
Read more »
Hedge fund Shah Capital recommends two new candidates for Novavax boardExplore stories from Atlantic Canada.
Read more »
Sanofi Is Said to Ask Banks to Pitch for $20 Billion OTC SpinoffFrench drugmaker Sanofi has asked banks to pitch for roles on the separation of its consumer-health business, according to people familiar with the matter, one of the biggest deals likely to happen in Europe this year.
Read more »
Sanofi Posts Strong Sales Growth With New Hemophilia MedicineSanofi posted first-quarter revenue that exceeded estimates as strong demand for its new hemophilia medicine helped make up for some unfavorable currency movements.
Read more »
Novavax's top shareholder Shah Capital ramps up efforts for board shakeupExplore stories from Atlantic Canada.
Read more »
BofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi SpinoffBank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging Sanofi’s separation of its consumer-health business, according to people familiar with the matter, in one of the year’s most sought-after banking assignments.
Read more »